Penn Capital Management Company LLC acquired a new stake in shares of Palvella Therapeutics, Inc. (NASDAQ:PVLA – Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 5,506 shares of the company’s stock, valued at approximately $841,000. A number […]

Ieq Capital LLC purchased a new position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the 2nd quarter, HoldingsChannel.com reports. The fund purchased 292,962 shares of the biotechnology company’s stock, valued at approximately $1,219,000. Other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada lifted its […]